JosephPNegliaMD
Pediatric Hematology & Oncology • Minneapolis, MNProfessor, Pediatrics, University of Minnesota Medical School
Dr. Neglia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2450 Riverside Ave
Journey Clinic
Minneapolis, MN 55454Phone+1 612-624-3113Fax+1 612-626-6601
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1984 - 1987
Baylor College of Medicine (Houston)Residency, Pediatrics, 1981 - 1984
Loma Linda University School of MedicineClass of 1981
Certifications & Licensure
MN State Medical License 1986 - 2025
SD State Medical License Active through 2025
ND State Medical License 1998 - 2002
TX State Medical License 1982 - 1987- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia Start of enrollment: 2004 Mar 01
- Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia Start of enrollment: 2004 May 01
- Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Start of enrollment: 2007 May 01
- Join now to see all
Publications & Presentations
PubMed
- Keratinocyte carcinomas in survivors of childhood cancer: A report from the childhood cancer survivor study.Christina Boull, Yan Chen, Cindy Im, Alan Geller, Yadav Sapkota
Journal of the American Academy of Dermatology. 2024-12-01 - The Feasibility and Acceptability of a Data Capture Methodology in Pediatric Cancer Patients Treated with Targeted Agents and Immunotherapies.Karim Thomas Sadak, Taiwo Opeyemi Aremu, Seah Buttar, Daniel Van Ly, Brenda Weigel
Current Oncology. 2024-01-25 - 6 citationsSubsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer.Yuehan Wang, Cécile M Ronckers, Flora E van Leeuwen, Chaya S Moskowitz, Wendy Leisenring
Nature Medicine. 2023-09-01
Journal Articles
- Risk of Solid Subsequent Malignant Neoplasms After Childhood Hodgkin Lymphoma–Identification of High‐Risk Populations to Guide Surveillance: A Report from the Late Eff...David Tishler, Anna T Meadows, Joseph P Neglia, Kimberley Dilley, Rajaram Nagarajan, Laura T Martin, Lisa R Diller, Cancer
Press Mentions
- M Health Fairview University of Minnesota Masonic Children’s Hospital Is Twin Cities’ Top-Ranked Children’s Hospital, According to U.S. News & World ReportJune 15th, 2021
M Health Fairview University of Minnesota Masonic Children’s HospitalJune 16th, 2020
University of Minnesota Masonic Children's Hospital Named One of the Nation's Best HospitalsJune 19th, 2019- Join now to see all
Grant Support
- Bedside To Bench And Back Again: Training Pediatricians In Translational ResearchEunice Kennedy Shriver National Institute Of Child Health &Human Development2011–2012
- Childrens Cancer GroupNational Cancer Institute1999–2002
- Children'S Cancer GroupNational Cancer Institute1997–1998
- Second Malignant Neoplasms Following Childhood LeukemiaNational Cancer Institute1987–1991
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
